Central Lumpectomy with Resection of the Nipple-areolar Complex for Retroareolar or Central Breast Cancers.
10.4174/jkss.2010.79.4.275
- Author:
Ra Joo LIM
1
;
Kyung Sang LEE
;
Suok Hyun LEE
;
Chan Seok YOON
;
Seung Sang KO
;
Min Hee HUR
;
Hae Kyung LEE
;
Sung Ran HONG
;
Ji Hyun LEE
;
Sung Soo KANG
Author Information
1. Department of General Surgery, Cheil General Hospital, Kwandong University College of Medicine, Seoul, Korea. kang1019@kwandong.ac.kr
- Publication Type:Original Article
- Keywords:
Central breast cancer;
Central lumpectomy;
Nipple-areolar complex (NAC)
- MeSH:
Aged;
Aromatase Inhibitors;
Breast;
Carcinoma, Intraductal, Noninfiltrating;
Chemotherapy, Adjuvant;
Cosmetics;
Follow-Up Studies;
Humans;
Hyperplasia;
Mastectomy, Segmental;
Nipples;
Recurrence;
Tamoxifen
- From:Journal of the Korean Surgical Society
2010;79(4):275-280
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: This study was conducted to evaluate the outcome of central lumpectomy for breast conservation including nipple-areolar resection and postoperative radiation therapy in patients with central breast cancers. METHODS: 19 patients with central breast cancers, aged 39 to 72 years, operated on from May 2004 to March 2010 were identified. Recurrence, survival, and cosmesis were analyzed. Treatment was undertaken as complete excision of the nipple-areolar complex (NAC), followed by external radiation to the whole breast and tumor bed. The mean follow-up period was 37.9 (1 to 71) months. RESULTS: At pathology, 13 had invasive ductal carcinoma; 5 had ductal carcinoma in situ. 1 had neuroendocrine cancer. Only 1 had atypical ductal hyperplasia at resection margin; the remaining 18 were free margins. The mean tumor size was 1.6 cm (range, 0.8~4 cm) and the distance from the nipple was 0~1 cm. 37.5% had positive axillary nodes. Adjuvant chemotherapy was given for 12 patients, followed by radiation therapy. All 15 patients, who were hormone receptor positive, were given tamoxifen or aromatase inhibitors. With a mean follow up of 37.9 months, all 19 patients are alive and free of disease. Cosmetic results ranged from good to excellent in 18 (94.7%) patients, as judged by both the patients and the surgeons. CONCLUSION: Although this study needs further evaluation and long-term follow up, subareolar or central breast cancers can be successfully treated with breast conserving therapy using nipple-areolar resection and postoperative radiation therapy, along with acceptable cosmesis.
